Inflammatory reflex disruption in COVID-19

Area of Science:

• Immunology
• Neuroscience
• Infectious Diseases

Background:

• COVID-19, caused by SARS-CoV-2, is a global pandemic with varied severity.
• While primarily affecting lungs, COVID-19 impacts multiple organs and can trigger harmful cytokine storms.
• Neurological manifestations are increasingly recognized as significant extrapulmonary complications of COVID-19.

Purpose of the Study:

• To review the potential of the cholinergic anti-inflammatory pathway (CAP) in managing COVID-19.
• To explore how SARS-CoV-2 disrupts the CAP, a key endogenous anti-inflammatory mechanism.
• To investigate the link between CAP dysfunction, COVID-19 pathogenesis, and neurological symptoms.

Main Methods:

• Review of existing literature on COVID-19, cytokine storms, and the cholinergic anti-inflammatory pathway.
• Analysis of studies detailing SARS-CoV-2 interactions with the alpha7 nicotinic acetylcholine receptor.
• Examination of research on neurological manifestations in COVID-19 patients.

Main Results:

• The CAP acts as a crucial anti-inflammatory reflex, potentially beneficial in COVID-19.
• SARS-CoV-2 may impair the CAP by interacting with the alpha7 nicotinic acetylcholine receptor.
• Dysfunction of the CAP could contribute to severe COVID-19, cytokine storms, and neurological issues.

Conclusions:

• The cholinergic anti-inflammatory pathway presents a promising therapeutic target for COVID-19 management.
• Understanding SARS-CoV-2's impact on the CAP is vital for addressing severe disease and extrapulmonary manifestations.
• Further research into modulating the CAP may yield effective treatments for COVID-19-related inflammation and neurological complications.